BNNC: Hypoxia-Activated Photomolecular Glue for Cancer Treatment

A dataset from figshare, authored by Shuai Li and last updated on June 3, 2026, describes BNNC, a photomolecular glue designed for cancer treatment. The data likely contains results related to the synergistic degradation of Cyclin K and phototherapy in hypoxic tumor microenvironments. It is a small dataset, 226 bytes in size, shared under a CC-BY-NC-4.0 license.

Use Cases

• Analyzing the efficacy of hypoxia-activated drug delivery systems based on the described BNNC compound.
• Studying synergistic effects in cancer treatment based on the combination of (R)-CR8 and BSS-Et agents mentioned in the description.
• Evaluating tumor selectivity and biosafety profiles for novel phototherapeutic agents.
• Researching DNA damage and apoptosis pathways in breast cancer cells as referenced in the experimental analysis.

Strengths

• Dataset is explicitly licensed for non-commercial reuse under CC-BY-NC-4.0.
• The underlying research describes a specific, novel compound (BNNC) and its mechanism of action.

Limitations

• Dataset size is extremely small (226 bytes), indicating very limited scope or content.
• Row count and column-level documentation are absent; field semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare

Freshness

Last updated 2026-06-03 09:30:44; freshness should be verified.